2017 US Hospital Coagulation Testing Market

March 2017 | 411 pages | ID: 2EE3E830025EN
Venture Planning Group

Abstracts

This new report from VPGMarketResearch contains 411 pages, 28 tables, and presents a comprehensive analysis of the US hospital coagulation testing market, including:

• Major issues pertaining to the US hospital coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.

Volume and sales forecasts for 40 coagulation procedures performed in US hospitals, including typical coagulation daily work loads.

Review of current instrumentation technologies, and a feature comparison of leading analyzers.

Reagent and instrument sales forecasts.

Sales and market shares of leading reagent and instrument suppliers.

Review of coagulation technologies and their potential market applications.

Major opportunities for new coagulation instruments and consumables.

Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Business opportunities and strategic recommendations for instrument and reagent suppliers.

Contains 411 pages and 28 tables

Contents

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Coagulation Tests
  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Alpha-2 Antiplasmin
  4. Antithrombin III
  5. Bleeding Time
  6. D-Dimer
  7. Ethanol Flocculation Test
  8. Euglobulin Lysis
  9. Factor Assays
    a. Introduction
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
  10. Fibrin Degradation Products
  11. Fibrinogen
  12. Heparin
  13. Hirudin
  14. Hypercoagulability and Thrombosis
  15. Lipoprotein a
  16. Plasmin
  17. Plasminogen
  18. Plasminogen Activator Inhibitor (PAI)
  19. Platelet Function Tests
  20. Platelet Aggregation
  21. Proteins C and S
  22. Prothrombin Fragment 1.2
  23. Prothrombin Time (PT)
  24. Reptilase Time
  25. Thrombin Time
  26. Tissue-Type Plasminogen Activator (t-PA)
  27. Von Willebrand's Factor
B. Instrumentation Review
  Introduction
  Benk Hemolab
  Benk TRT Thrombotimer
  Bio/Data MCA
  Bio/Data MCA
  Bio/Data PAP-4C D/4D/4C
  Cardiovascular Diagnostics COAG
  Diagnostica Stago STA Compact
  Diagnostica Stago STA-R
  Diagnostica Stago Star 4/8
  Helena Laboratories Cascade
  Helena Laboratories Cascade M
  Helena Laboratories PACKS-4
  Helena THOR
  Instrumentation Laboratory ACL 100 and 1000 series
  Instrumentation Laboratory ACL6000
  Instrumentation Laboratory ACL7000
  Instrumentation Laboratory ACL9000
  Instrumentation Laboratory Electra 1000C
  Instrumentation Laboratory Electra 1400C
  Instrumentation Laboratory Electra 1600/C
  Instrumentation Laboratory Electra 1800C
  Instrumentation Laboratory Futura
  ITC Hemochron 8000
  Roche Diagnostics CoaguChek
  Siemens BCS
  Siemens BCT
  Siemens BF II/Fibrintimer Series
  Sysmex CA-50
  Sysmex CA-500
  Sysmex CA-1500
  Sysmex CA-5000/CA-1000
  Sysmex CA-6000
  Sysmex CA-7000
  Teco Coatron II/Jr./AccuStasis 5000
  Trinity Biotech Amax CS190
  Trinity Biotech Amax CS400
  Trinity Biotech Coag-A-Mate Max
  Trinity Biotech KC 40, 4A, 1A Series
  Trinity Biotech MDA
  Trinity Biotech Coag-A-Mate MTX
  Trinity Biotech Coag-A-Mate RA4
  Trinity Biotech Coag-A-Mate XC/Plus
  Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
  1. Chromogenic Substrates
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
    a. Applications
    b. Technological Principle
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Dot Immunobinding Assays
      Capillary Immunoassays
      Enzyme Amplification
      Electrochemical Immunoassay
    d. Fluorescent Immunoassays
      Fluorescence Polarization
      Time-Resolved Pulse Fluorescence
      Fluorescence Lifetime
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Microcomputers
  5. Automation
  6. Robotics
  7. DNA Probes
    a. Overview
    b. Amplification Methods
      PCR
      Ligase Chain Reaction
      Branched DNA
      Q-Beta Replicase
      NASBA
      SDA
      3 SR
    HPA
      Two-Tiered System
      LAT
  8. Artificial Intelligence
  9. Dry Chemistry
  10. Biosensors

USA

A. Executive Summary
B. Business Environment
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Industry Consolidation
  4. Managed Care
  5. Hospitals
  6. Admissions
  7. Length of Stay
  8. Industry Diversification
  9. Physician Demographics
  10. Population Aging
    a. Chronic Illnesses
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
  11. Laboratory Regulations
C. Market Structure
  1. Centralized Testing
    a. Hospitals
    b. Commercial laboratories
  2. Decentralized Testing
    a. Physician Offices/Group Practices
    b. Point-of-Care Testing
    c. Home/Self Testing
    d. Other Decentralized Testing Locations
D. Market Size, Growth And Major Suppliers

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
American Diagnostica
Avocet Medical
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Biosite
Chrono-Log
Corgenix Medical
Diagnostica Stago
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Nanogen
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
Trinity Biotech
ZyCare

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table: U.S.A., Hospital Coagulation Diagnostics Market By Product Category
U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
U.S.A., Hospital Laboratories Average Daily Test Volume
U.S.A., Hospital Laboratories Coagulation Test Volume by Assay
U.S.A., Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Sales and Market Shares
U.S.A., Coagulation Diagnostics Market By Product Category
U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares